Delivery Order SPE2DB20D3303-SPE2DB25FA2JQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,387.27 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within...
- The Defense Logistics Agency awarded a delivery order valued at $39,850.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $5,392.64 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and is being fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. Jardiance is a prescription medication used to manage type 2 diabetes, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $7,191.99 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used to treat type 2 diabetes in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $6,496.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $11,632.89 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly prescribed for type 2 diabetes management, reflecting the critical pharmaceutical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $4,765.67 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used primarily for managing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $18,493.98 and is scheduled for completion by August 4, 2025. The contract involves no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. Jardiance is a widely-used...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2JQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,052.95 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used by military service members and veterans through the Defense Health Agency and other federal healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to meet diverse medical supply requirements across varying order sizes and therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/11/25 |